Value of hematological parameters as biomarkers of disease manifestations and severity in systemic sclerosis
Authors:
- Basma R. SakrBSBasma R. Sakr
- Randa E. RabeaRRRanda E. Rabea
- Samah MAbd ElHamidSESamah MAbd ElHamid
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in The Egyptian Rheumatologist
- Vol. 43 (2) , 159-165
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2013
- Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic SclerosisInflammation, 2013
- Red blood cell distribution width is a potential prognostic index for liver diseaseClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of HistonesPLOS ONE, 2012
- Neutrophil-derived reactive oxygen species in SScRheumatology, 2012
- Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studiesRheumatology, 2010
- Assessing microvascular changes in systemic sclerosis diagnosis and managementNature Reviews Rheumatology, 2010
- Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptorBlood, 2006
- Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1β, and tumour necrosis factor α in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosisJournal of Clinical Pathology, 2005
- SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsivenessBlood, 2004